Draegerwerk AG & Co KGaA (ETR:DRW3) PT Set at €96.00 by Warburg Research

Draegerwerk AG & Co KGaA (ETR:DRW3) received a €96.00 ($110.34) price objective from equities research analysts at Warburg Research in a report released on Friday. The brokerage presently has a “neutral” rating on the stock.

DRW3 has been the topic of a number of other reports. DZ Bank AG reaffirmed a “sell” rating on shares of Draegerwerk AG & Co KGaA in a research note on Saturday, May 20th. Deutsche Bank AG set a €91.00 ($104.60) price objective on Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research note on Wednesday, July 5th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of €97.00 ($111.49).

Draegerwerk AG & Co KGaA (ETR DRW3) opened at 94.493 on Friday. The firm’s 50-day moving average price is €101.06 and its 200 day moving average price is €90.89. Draegerwerk AG & Co KGaA has a one year low of €51.01 and a one year high of €107.63. The firm has a market capitalization of €1.68 billion and a P/E ratio of 27.581.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Stock Observer and is the property of of Stock Observer. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.thestockobserver.com/2017/07/18/draegerwerk-ag-96-00-by-warburg-research.html.

About Draegerwerk AG & Co KGaA

Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The Company operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care.

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply